HARBOURVEST PARTNERS LLC Quant / Systematic

Location: Boston, MA

CIK: 0001201001 · Show all filings

Period: Q4 2014 (← Previous) (Next →)

Filing Date: Feb 13, 2015

Total Value: $190M (100.0% shares, 0.0% debt)

Holdings (30)

W Wayfair 46.1%
Value $87.6M Shares 4,413,282 Est. Cost $24.01 Unrealized 0.0%
ServiceMaster Global Holdings, Inc. 23.5%
Value $44.62M Shares 1,666,666 Est. Cost $26.77 Unrealized
Finjan 6.1%
Value $11.62M Shares 4,303,435 Est. Cost $2.70 Unrealized
Tableau Software, Inc. 3.6%
Value $6.865M Shares 80,998 Est. Cost $84.76 Unrealized
Envivio 2.6%
Value $4.878M Shares 3,639,939 Est. Cost $2.02 Unrealized
VIPS VIPSHOP Holdings, Ltd. 2.5%
Value $4.813M Shares 246,304 Est. Cost $19.54 Unrealized
GAIN Capital Holdings, Inc. 2.5%
Value $4.722M Shares 523,508 Est. Cost $9.02 Unrealized
GOGO GOGO, Inc. 1.6%
Value $3.078M Shares 186,178 Est. Cost $23.14 Unrealized -29.6%
Clovis Oncology, Inc. 1.5%
Value $2.858M Shares 51,037 Est. Cost $56.00 Unrealized
SolarCity Corporation 1.1%
Value $2.079M Shares 38,870 Est. Cost $53.49 Unrealized
Marketo, Inc. 1.1%
Value $2.055M Shares 62,798 Est. Cost $32.72 Unrealized
Zulilly, Inc. 1.0%
Value $1.997M Shares 85,355 Est. Cost $23.40 Unrealized
Acceleron Pharma Inc. 1.0%
Value $1.993M Shares 51,163 Est. Cost $38.95 Unrealized
Foundation Medical, Inc. 1.0%
Value $1.955M Shares 87,991 Est. Cost $22.22 Unrealized
HomeAway, Inc. 0.8%
Value $1.496M Shares 50,244 Est. Cost $29.77 Unrealized
Kythera Biopharmaceuticals, Inc. 0.7%
Value $1.364M Shares 39,318 Est. Cost $34.69 Unrealized
MGNX MacroGenics, Inc. 0.7%
Value $1.349M Shares 38,452 Est. Cost $24.93 Unrealized 0.0%
ARDX Ardelyx, Inc. 0.5%
Value $898K Shares 47,520 Est. Cost $23.16 Unrealized 0.0%
Cara Therapeutics, Inc. 0.4%
Value $672K Shares 67,452 Est. Cost $9.96 Unrealized
ChannelAdvisor Corporation 0.3%
Value $615K Shares 28,512 Est. Cost $21.57 Unrealized
Applied Genetic Technologies Corporation 0.3%
Value $598K Shares 28,443 Est. Cost $21.02 Unrealized
RetailMeNot, Inc. 0.3%
Value $591K Shares 40,420 Est. Cost $14.62 Unrealized
Hyperion Therepeutics, Inc. 0.2%
Value $450K Shares 18,758 Est. Cost $23.99 Unrealized
E2open, Inc. 0.2%
Value $338K Shares 35,140 Est. Cost $9.62 Unrealized
KalosBios Pharmaceuticals, Inc. 0.1%
Value $186K Shares 107,604 Est. Cost $1.73 Unrealized
OPOWER, Inc. 0.1%
Value $113K Shares 7,939 Est. Cost $14.23 Unrealized
Nektar Therapeutics, Inc. 0.1%
Value $108K Shares 6,974 Est. Cost $15.49 Unrealized
VCYT Veracyte 0.1%
Value $107K Shares 11,101 Est. Cost $7.80 Unrealized 0.0%
Epizyme, Inc. 0.1%
Value $98,000 Shares 5,196 Est. Cost $18.86 Unrealized
Arista Networks, Inc. 0.0%
Value $81,000 Shares 1,341 Est. Cost $60.40 Unrealized